Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 66 results for "zydus cadila"

Zydus Cadila receives USFDA nod to market fluconazole tablets
Money Control

Cadila Health: Zydus gets USFDA nod for Phase II clinical tria...

Zydus Cadila announced that the USFDA has approved the group�s plan to initiate a Phase 2 clinical trial of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis (PBC) of the liver. Money Control, 3 days ago

50 images for zydus cadila

Money Control, 2 days ago
Money Control, 1 week ago
Business Standard India, 1 month ago
Money Control, 1 month ago
Franchise India, 1 month ago, 1 month ago
DealStreetAsia, 1 month ago
India Infoline, 1 month ago
DealStreetAsia, 1 month ago
Odisha Television, 1 month ago
Money Control

Zydus Cadila to launch influenza fighting vaccine in India

The vaccine provides protection from four influenza viruses -- H1N1, H3N2, Type B (Brisbane)
 Business Standard2 days ago Zydus Cadila to launch seasonal flu vaccine in India  DNA2 days ago
Money Control

Zydus acquires Sentnyl, a US specialty pharma company

A leading global healthcare company, Zydus Cadila on January 19, announced that ithas acquired Sentnyl Therapeutics Inc., which is a US based specialty in the pharmaceutical business.
 India Infoline1 month ago Zydus Cadila acquires Sentynl Therapeutics Inc  Money Control1 month ago Zydus Cadila acquires US-based Sentynl Therapeutics  Business Standard1 month ago Zydus Cadila open for buyouts in the US  Business Standard1 month ago

Aim to develop and market molecules in India first: Zydus Cadila

In an interview with CNBC-TV18, Pankaj R Patel, CMD, Zydus Cadila Healthcare, talked about the company's business strategy, progress with molecule research and earnings outlook.
 Money Control3 weeks ago Pankaj Patel takes over as FICCI president  DNA2 months ago Pankaj Patel takes over as President of FICCI  Business Standard2 months ago
Money Control

Cadila's subsidiary settles its patent litigation

Zydus Pharmaceuticals (USA) Inc., a subsidiary of Cadila Healthcare Limited, which is a global pharmaceuticals company, has today announced that they have finalised an agreement with Upsher-Smith Laboratories Inc., to settle the patent litigation with ...
 India Infoline1 month ago Cadila settles patent litigation related to Livalo tablets  Business Standard1 month ago
Money Control

Zydus arm acquires six drugs from MSD

Pharma major Zydus Cadila on Wednesday announced that its healthcare arm had acquired six brands from US drug maker MSD and its subsidiaries for an undisclosed amount.The Mumbai-based MSD is the Indian subsidiary of the American global pharmaceutical ...
 Prokerala1 month ago Zydus Cadila acquires 6 brands from MSD  Business Standard1 month ago Cadila Healthcare provides update on subsidiary - Zydus Healthcare  Business Standard1 month ago Zydus Healthcare Arm Acquires Six Drugs from United States Drug Maker MSD  Med India1 month ago

Zydus Cadila settles DELZICOL (Mesalamine) patent litigation

Likely to market generic version of DELZICOL in US in early March 2017
 Business Standard2 months ago Zydus Cadila settles patent case  Business Line2 months ago Zydus can launch ulcer drug in US, patent litigation settled  Money Control2 months ago Zydus announces settlement of patent litigation  India Infoline2 months ago
Money Control

Zydus recalls over 16k bottles of anti-depressant drug in US

Zydus Pharmaceuticals USA Inc is the US arm of Zydus Cadila's listed entity Cadila Healthcare
 Business Standard1 month ago

Zydus settles case with Upsher-Smith on Qudexy

Pharmaceuticals company Cadila Healthcare and its subsidiary Zydus Pharmaceuticals (US) have finalised an agreement with Upsher-Smith Laboratories, a regulatory filing said here on Friday.This would settle all outstanding patent litigation related to Qudexy ...
 Prokerala1 month ago

Sensex Opens Flat, Cadila Healthcare Slumps 1.7%

Posted by Equitymaster Asian markets are lower in morning trade as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.98% while the Hang Seng is down 0.06%. The Shanghai Composite is trading flat. Stock markets in US closed their previous session on ...
 Equitymaster.com1 month ago Global Markets Continues to be Volatile  Equitymaster.com1 month ago Sensex Finishes Marginally Lower; TCS Gains 0.9%  Equitymaster.com1 month ago Sensex Opens Firm; Rupee Edges Higher by 3 Paise  Equitymaster.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less